1002 POSTER The usefulness of FDG-PET in predicting response to neoadjuvant chemotherapy (NCT) in patients with locally-advanced breast cancer (LABC)

M.E.Schneider-Kolsky; P.Midolo; S.Hart; J.Stuckey; A.Baldey; J.Fox; P.A.W.Rogers; A.Strickland; B.Susil; V.Ganju

首页> 外文期刊>European Journal of Cancer Supplements >1002 POSTER The usefulness of FDG-PET in predicting response to neoadjuvant chemotherapy (NCT) in patients with locally-advanced breast cancer (LABC)

【24h】

1002 POSTER The usefulness of FDG-PET in predicting response to neoadjuvant chemotherapy (NCT) in patients with locally-advanced breast cancer (LABC)

机译：1002 POSTER FDG-PET在预测局部晚期乳腺癌（LABC）患者对新辅助化疗（NCT）的反应中的作用

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共1页
作者
M.E.Schneider-Kolsky; P.Midolo; S.Hart; J.Stuckey; A.Baldey; J.Fox; P.A.W.Rogers; A.Strickland; B.Susil; V.Ganju;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 552 POSTER Identification of predictive markers for tumour response to neo-adjuvant chemotherapy (NCT) treatment for locally-advanced breast cancer (LABC) [J] . V.Ganju, A.Strickland, S.Hart, European Journal of Cancer Supplements . 2007,第4期

机译：552海报鉴定局部晚期乳腺癌（LABC）对新辅助化疗（NCT）治疗肿瘤反应的预测标志物
2. Updated results of the assessment of the role of her-2 overexpression as a predictive factor to neoadjuvant, anthracycline-containing chemotherapy in locally-advanced breast cancer (LABC) [J] . B.Bauer-Kosinska, Lemanska, D.Larecka, European Journal of Cancer Supplements . 2006,第2期

机译：评估Her-2过表达作为局部辅助性乳腺癌（LABC）中新的含蒽环类化疗的预测因子的作用的评估结果的更新结果
3. 5174 Predictive factors of response to neoadjuvant 3-weekly epirubicin (EPI) plus docetaxel (DOC) chemotherapy (CT) in locally advanced breast cancer (LABC): a prospective phase II trial [J] . M.R.Strada, M.Frascaroli, R.Palumbo, European Journal of Cancer Supplements . 2009,第2期

机译：5174在局部晚期乳腺癌（LABC）中对新辅助药物每周3次表柔比星（EPI）联合多西他赛（DOC）化疗（CT）的反应的预测因素：一项前瞻性II期试验
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT) [O] . Shengyu Pu, Ke Wang, Yang Liu, 2020

机译：Neoadjuvant化疗治疗乳腺癌患者病理完全反应（PCR）的载体衍生预测（NCT）
7. A Simple Risk Scoring System for Predicting Recurrence in Women with Locally Advanced Breast Cancer (LABC) Treated with Neoadjuvant Chemotherapy (NACT) [O] . Sushma Agrawal, Prabhakar Mishra, Anjali Mishra, 2021

机译：一种简单的风险评分系统，用于预测局部晚期乳腺癌（Labc）治疗新辅助化疗（NACT）的妇女复发

1002 POSTER The usefulness of FDG-PET in predicting response to neoadjuvant chemotherapy (NCT) in patients with locally-advanced breast cancer (LABC)

著录项

引文网络

相似文献

相关主题

期刊订阅